Anti-diabetic effect of ethanol leaf extract of Cissampelos owariensis (lungwort) on alloxan induced diabetic rats by Ekeanyanwu, RC et al.
African Journal of Biotechnology Vol. 11(25), pp. 6758-6762, 27 March, 2012     
Available online at http://www.academicjournals.org/AJB 
DOI: 10.5897/AJB12.512 





Full Length Research Paper 
 
Anti-diabetic effect of ethanol leaf extract of 
Cissampelos owariensis (lungwort) on alloxan induced 
diabetic rats 
 
Ekeanyanwu, R. C.1*, Udeme, A. A.2, Onuigbo, A. O.2 and Etienajirhevwe O. F.3 
 
1
Department of Biochemistry, Imo State University, Owerri, Imo State, Nigeria. 
2
Department of Chemical Sciences, Biochemistry Unit, Novena University, Ogume, Delta State, Nigeria. 
3
Department of Science Laboratory Technology, Delta State Polytechnic, Otefe, Delta State, Nigeria. 
 
Accepted 14 March, 2012 
 
Cissampelos owariensis (lungwort) is a medicinal plant used in Ayurveda for treating diseases. One of 
such disease is diabetes mellitus. In the present study, ethanol leaf extract of this plant was prepared, 
and phytochemical composition, acute toxicity, blood glucose lowering effect and improvement of body 
weight gain in alloxan monohydrate (150 mg/kg weight) induced diabetic rats were measured and 
compared with that of a patent drug glibenclamide. Preliminary phytochemical screening of the ethanol 
leaf extract of C. owariensis revealed the presence of tannins, flavonoids, alkaloids and saponins. The 
median lethal dose (LD50) in rats was 2154 mg/kg body weight (b.wt). Rats were administered C. 
owariensis extract at dose rate of 100 and 200 mg/kg b.wt orally for 14 days, respectively. Blood 
glucose concentration and body weight was measured by Accu Chek Glucometre test kit and electronic 
balance and compared with a patent drug glibenclamide at a dose rate of 100 mg/kg b.wt. The data were 
compared statistically by using analysis of variance (ANOVA). The herbal preparation of C. owariensis 
significantly (P<0.05) increased body weight gain and decreased blood glucose when compared with 
patent drug. The present study clearly indicated anti-diabetic activity of C. owariensis and supports the 
traditional usage of the herbal preparations for the therapy of diabetics. 
 





Diabetes mellitus is a multi factorial disease which is 
characterised by hyperglycaemia (Scoppola et al., 2001; 
Ugochukwu et al., 2003), lipoprotein abnormality 
(Scoppola et al., 2001), raised basal metabolic rate 
(Avesani et al., 2001; Nawata et al., 2004; Owu et al., 
2006), defect in reactive oxygen species scavenging 
enzymes (Kesavulu et al., 2000) and altered intermediary 
metabolism of major food substances (Avesani et al., 
2001; Unwin et al., 2001; Nawata et al., 2004). Diabetes 
is a major degenerative disease in the world today 
(Ogbonnia et al., 2008) affecting at least 171 million 
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hypertension, atherosclerosis and micro circulatory 
disorders. Nowadays, various medicinal plants are 
becoming very popular in the treatment of different 
diseases all over the world. There are a number of plants 
that control blood glucose level such as Azadirachta 
Indica, Catharanthus roseus, Allium sativum, Memordica 
judaica, Aloe vera, Trigonella foenum greacum, etc.  
Cissampelos is a medicinal plant belonging to the 
kingdom plantae, phylum tracheophyta, class mango-
liopsida, order ranunculales, genus Cissampelos and 
species Cissampelos owariensis (Baerts and Lehmann, 
2006). It is known in Nigeria as jokoje in Yoruba and 
ebubueka enwe in Ukwuani. Through out the distribution 
of C. owariensis, people take the infusion of the bitter 
rhizome, leaves or stems to cure gastrointestinal 
complaints such as diarrhoea, dysentery, colic, intestinal 





problems such as menstrual problems, venereal diseases 
and infertility. It is also used to induce contraction of the 
uterus to start labour or abortion and to expel the 
placenta. Women of the Bini in Nigeria use the leaves to 
promote foetal growth (Burkhill, 1994).  
Plants which had been shown to have hypoglycaemic 
action, act on blood glucose through several mecha-
nisms. Some of them may inhibit endogenous glucose 
production (Eddouks et al., 2003) or interfere with 
gastrointestinal glucose absorption (Musabayane et al., 
2006); some may have insulin-like substances (Collier et 
al., 1987; Gray and Flatt, 1999); some may inhibit 
insulinase activity and some may increase secretion of 
insulin from β cells of the pancreas (pancreatotrophic 
action) (Khan et al., 1990; Trivedi et al., 2004; Yadav et 
al., 2008), while others may proliferate β cells in pancreas 
by activating regeneration of these cells 
(Shanmugasundaram et al., 1990). Very few traditional 
treatments for diabetes mellitus have been scientifically 
examined. The aim of this study was to evaluate the 
possible anti-diabetic action of C. owariensis and to 
examine the safety and efficacy of this plant in the 
management of diabetes mellitus. 
 
 
MATERIALS AND METHODS 
 
The experiment was performed in the laboratory of the Department 
of Chemical Sciences, Biochemistry Unit, Novena University, 
Ogume, Delta State, Nigeria for a period of 2 months to evaluate 
the efficacy of lungwort and glibenclamide on alloxan monohydrate 
induced diabetic rats. 
 
 
Collection and acclimatisation of rats  
 
Mixed albino rats aged 2 months, with average weight of 113 g 
were collected from the Animal House of the College of Health 
Science, Delta State University, Abraka, Delta State, Nigeria. Rats 
were grouped into five groups, each containing seven animals. 
Each group of rats were housed at serene bottomed wire cages 
arranged in rows. The animals were housed in standard 
environmental conditions of temperature (21 ± 2°C), humidity (55 ± 
10%) and a 12 h light-dark cycle. The animals were fed with 
palletised feed and water ad libitum. The rats were maintained in 
this condition for a period of three weeks to acclimatise them prior 
to experimental uses. 
 
 
Collection and preparation of plants extract  
 
Fresh leaves of C. owariensis were collected from Amai, Delta 
State, Nigeria in the month of May and June, 2011. The plant was 
botanically identified and authenticated by Professor J. M. O. Eze of 
the Laboratory of Ethno Botanical Research, Biological Sciences 
Department of Novena University, Ogume in Delta State, Nigeria 




Preparation of ethanol extract  
 
One litre of ethanol (Analar Grade) was added  to  37 g  of  shaded,  




dried and ground leaves that was packed into a container, cocked 
and left to stand for 48 h with occasional shaking. The whole mass 
was filtered out in a cotton cloth and then through Whatman No. 1 
filters paper and concentrated in a water bath at 65°C into slurry. 
 
 
Phytochemical screening of the extract  
 
The phytochemical study for the presence of flavonoids, alkaloids, 
tannins and saponins in the ethanol extract was done according to 





0.1 g of each of the extract was added to a mixture of 10 ml of lead 
acetate solution (90% w/v) and 20 ml of 50% aqueous ethanol in a 
200 ml conical flask. The mixture was placed on boiling water for 2 
min, cooled and filtered. Five milliter (5 ml) of dilute ammonia was 
added to a portion of the aqueous filtrate followed by the addition of 
concentrated sulphuric acid (1 ml) to 2 ml of potassium hydroxide 
solution and allowed to mix. Then, into the acid base mixture, a 
small quantity of aqueous filtrate of the sample was added and 





0.2 g of the extract was added to 5 ml of 2% hydrochloric acid and 
heated on boiling water for 10 min. It was then allowed to cool and 
then filtered. To 1 ml of the filtrate in a test tube was tested 
alkaloids reagent, Wagner’s and Mayer’s reagent and results were 
compared with blank. Turbidity or precipitation indicated the 





0.2 g of the extract was boiled with 5 ml of 45% ethanol for 5 min. 
The mixture was filtered hot using a filter paper and filtrate was 
collected in a beaker. Two milliter (2 ml) of the filtrate was mixed 
with 10 ml of distilled water and then a drop of iron chloride solution 
was added. A blue-black or blue-green precipitate indicates the 





0.1 g of each of the extract was measured into a beaker and 20 ml 
of distilled water was added, the beaker was heated in a water bath 
for over 5 min. The mixture was filtered using a filter paper into 
another beaker to obtain a filtrate. Two milliter (2 ml) of the filtrate 
was poured in another test tube and 10 ml of distilled water was 
added, it was shaken vigorously for over a minute. Frothing which 
persist on warming indicated the presence of saponin. 
 
 
Acute toxicity study  
 
Acute toxicity study on the ethanol leaf extract was carried out 
according to the method of Lorke (1983) using 21 mice of average 
weight of 22.8 g that were dosed orally with different gradual doses 
(0.01 to 5 g/kg body weight). In the first phase, 9 mice were divided 
into 3 groups of 3 mice each and were treated with the ethanol 
extract of the plant at doses of 0.01, 0.1 and 1.0 g/kg body weight 
orally. They were observed for 24 h for signs of toxicity. In the 
second phase, 12 mice were divided into 4 groups of 3 mice each 
and  were  also  treated with the aqueous extract at doses of 1, 1.6, 




Table 1. The phytochemical composition of the ethanol leaf 
extracts of C. owariensis. 
 






+++ = Present in high amount, ++ = present in moderately high 




2.9 and 5.0 g/kg bodyweight orally. The median lethal dose (LD50) 
was calculated as the geometric mean of the highest non lethal 
dose (with no death) and the lowest lethal dose (where death 
occurred).  
 
LD50 = Square root of the product of minimum toxic dose and 
maximum tolerated dose 
 
 
Collection and preparation of the anti-diabetic drug 
 
The oral anti-diabetic drug used was glibenclamide Daonil
®
. The 
glibenclamide was dissolved in distilled water to make a 




Doses for biological investigations 
 
The doses used for pharmacological studies were 100 and 200 
mg/kg body weight of the ethanol extract, chosen based on our 
result of the toxicity study of the extract on mice.  
 
 
Experimental design  
 
From the thirty five rats collected, twenty eight were rendered 
diabetic after single intraperitoneal injections of alloxan 
monohydrate in a dose of 150 mg/kg body weight (Edem, 2009). 
The rest (untreated rats) served as non-diabetic rats (control 
group). The diabetic and non diabetic rats were divided into five 
groups of rats and were treated as follows: Group 1, non diabetic 
rats (control group) were not administered alloxan monohydrate; 
Group 2, diabetic non-treated rats (diabetic control); Groups 3 and 
4, diabetic rats were orally given the ethanol extract of C. 
owariensis at doses of 100 and 200 mg/kg body weight, 
respectively for 14 days; Group 5, diabetic rats were given single 
oral dose of anti-diabetic drug glibenclamide as a reference drug at 
100 mg/kg body weight for 14 days. 
Rats induced with alloxan monohydrate were administered 5% 
glucose solution during the first 24 h. Blood glucose levels in 
alloxan treated mice were measured after 72 h. Alloxan injection 
was done by intra peritoneal injection of 150 mg/kg body weight of 
alloxan monohydrate (Sigma) dissolved in sterile distilled water and 
animals that remained alive after the alloxan injection and with 
blood glucose levels above 200 mg/dl were considered diabetic. 
The administration (p.o) was started from the same day, except 
normal control and diabetic control groups for a period of 14 days. 
During this period, animals in all groups had free access to 
standard diet and water. The blood glucose level as well as the 
body weight of all treated animals (Groups 2 to 5), normal group 
(Group 1) and diabetic group (Group 2) were taken pre and post 
day 0 and  7
th
,  and  14
th





Table 2. LD50 estimation. 
 
Treatment  Number used/number dead 
Phase I  
Group 1 (10 mg/kg) 3/0 
Group 2 (100 mg/kg) 3/0 
Group 3 (1000 mg/kg) 3/0 
  
Phase II 
Group 1 (1000 mg/kg) 
Group 2 (1600 mg/kg) 
3/0 
3/0 
Group 3 (2900 mg/kg) 3/1 




Glucose Monitoring Kit (Roche Diagnostics, GmbH, Mannheim, 
Germany) and weighing balance, respectively. Blood was collected 
from overnight fasted rats using the orbital technique (Ekeanyanwu 
and Njoku, 2010) 
 
 
Statistical analysis  
 
Results were expressed as mean±standard deviation. Differences 
between normal and treated groups were the criteria for the 
pharmacological activities. Statistical analysis of results were done 
using one way ANOVA, calculated using SPSS (statistical tool for 





Phytochemical composition  
 
The phytochemical analysis of the ethanol leaf extract of 
C. owariensis showed that it contains in high concen-
tration, phytochemicals like saponins, tannins and flavo-
noids but alkaloids were found in moderately high 
concentration (Table 1). 
 
 
Acute toxicity study (LD50)  
 
The result of the acute toxicity study showed that mice 
administered ethanol leaf extract of C. owariensis for 
doses between 10 and 1600 mg/kg did not experience 
any fatality. But mice administered doses of 2900 and 
5000 mg/kg experienced fatality (Table 2). The LD50 was 
calculated as the geometric mean of the highest dose 
that did not kill mice and the least dose that killed mice. 
 
LD50 = √ (1600 × 2900) = 2154 mg/kg 
 
 
Effect of ethanol leaf extract of C. owariensis on body 
weight of control and experimental rat  
 
Normal control rats were found to be stable in their body 
weight but diabetic  rats  showed  significant  reduction  in  




Table 3. Effect of ethanol leaf extract and glibenclamide tablet on body weight gain in normal and alloxan treated diabetic rats. 
 
Group Treatment  (mg/kg b.wt) (PO) 
Body weight (g) (n=7) 
Day 0 Day 7 (Mean±SD) Day 14 (Mean±SD) 
1 Normal control 100.00±16.33 127.33±15.53* 121.33±16.74* 
2 Diabetic control 115.50±17.33 101.33±11.02* 92.50±0.70* 
3 Ethanol leaf extract (100mg/kg b.wt) 123.75±17.29 142.00±7.21* 141.33±2.31* 
4 Ethanol leaf extract (200mg/kg b.wt) 114.50±12.92 137.33±8.33* 134.67±5.77* 
5 Glibenclamide tablet 112.75±17.23 124.00±15.87* 120.00±19.29* 
 




Table 4. Effect of ethanol leaf extract and glibenclamide tablet on blood glucose in normal and alloxan treated diabetic rats. 
 
Group Treatment  (mg/kg b.wt) (PO) 
Blood glucose concentration (g/dl) (n=7) 
Day 0 Day 7 (Mean±SD) Day 14 (Mean±SD) 
1 Normal control 129.00±6.24 108.00±14.73 102.00±17.54 
2 Diabetic control 214.00±1.41 222.00±32.97* 263.67±12.89* 
3 Ethanol leaf extract (100mg/kg b.wt) 217.00±2.82 209.33±16.07* 175.50±9.19* 
4 Ethanol leaf extract (200mg/kg b.wt) 214.50±6.03 207.00±7.00* 189.67±7.23* 
5 Glibenclamide tablet 213.00±7.00 188.00±8.54* 82.50±9.19* 
 




body weight during the 14 days of experiment. Diabetic 
treated rats placed on 100 and 200 mg/kg extract and 
glibenclamide experienced significant increase in the 
body weight during the 14 days experiment (Table 3). 
 
 
Effect of blood glucose level on normal and 
experimental rat  
 
Ethanol leaf extract of C. owariensis was subjected to 
anti-diabetic activity in rats where alloxan monohydrate 
(150 mg/kg b.wt. i.p) was used as the diabetogenic 
agent. A marked rise in fasting blood glucose level was 
observed in diabetic control when compared with the 
normal control rats. Ethanol extract of C. owariensis (at 





 day of administration. The 
hypoglycaemic effect of ethanol leaf extract was found to 
be less effective than the reference standard; gliben-
clamide produced a significant reduction in blood glucose 





Medicinal plants are widely used by the populations of 
underdeveloped countries as alternative therapy. In 
Africa, hundreds of plants are used traditionally for the 
management and/or control of diabetes mellitus. Unfor-
tunately, only a few of such African medicinal plants have 
received scientific examination. 
The percentage yield of the ethanol leaf extract of C. 
owariensis was found to be 5.4%. Phytochemical 
analysis of the ethanol extract of C. owariensis leaves 
extract revealed the presence of flavonoids, saponins, 
tannins, alkaloids as shown in Table 1. Secondary plant 
metabolites like polysaccharides, coumarins, flavonoids, 
terpenoids, arginine and glutamic acid are known to have 
hypoglycaemic effects in various experimental animal 
models (Akah and Okafor, 1992; Marles and Farnworth, 
1995; Ross, 2001; Ojewole, 2002). Tannin containing 
drugs have also been shown to demonstrate anti-diabetic 
activity (Iwu, 1980, 1983). Effect of the flavonoids on 
pancreatic β cells leading to their proliferation and 
secretion of more insulin have been proposed by Mahesh 
and Menon (2004) and Sri-Balasubashini et al. (2004) as 
the mechanism by which they reduced hyperglycaemia in 
diabetic rats. The presence of flavonoids in the ethanol 
crude extract of C. owariensis may also be acting simi-
larly, thereby decreasing the high blood glucose levels of 
alloxan-diabetic rats.  
The observed reduced activity of the treated mice in the 
initial period of extract administration showed that the 
extract possessed depressing effect. The LD50 was 
calculated to be 2154 mg/kg. 
After 14 days administration of C. owariensis leaf 
extract, blood glucose concentration decreased signify-
cantly (P<0.05) in comparison with day zero. Gliben-
clamide also decreased blood glucose concentration. 
After 14 days of administration of glibenclamide, the 
blood glucose concentration reduced significantly 
(P<0.05) which agreed with the  report  of  Sharma  et  al.  




(2010). Signs of regeneration of β cells, potentiating 
insulin secretion from surviving β cells of the islets of 
langerhans and decrease of blood glucose concentration 
have been reported following consumption of some plant 
extracts (Shanmugasundaran et al., 1990; Yadav et al., 
2008). C. owariensis leaf may have some chemical com-
ponents that exerts regenerative effects on β cells, 
stimulate these cells to produce more insulin (pancreato-
trophic action) or may have some insulin-like substances, 
and induction of regenerative stimulus in diabetic state 
triggers pancreatic regenerative processes, thereby 
restoring functional activities of the pancreases (Adewole 
and Ojewole, 2007). It has been reported that flavonoids 
and tannins present in plants extracts possess 
antidiabetic activity (Ojewole, 2002; Iwu, 1983). In the 
present study, the observed anti-diabetic potential of our 
test extract may be due to the presence of similar 
phytochemical constituents which was evident by our 
preliminary phytochemical screening. 
 
 
Conclusion   
 
From this study, we can state that the ethanol extract of 
C. owariensis has beneficial effects on blood glucose 
concentration. Further pharmacological and biochemical 
investigations will clearly elucidate the mechanism of 
action and will be helpful in projecting this plant as a 





Adewole SO, Ojewole JAO (2007). Insulin- induced 
immunohistochemical and morphological changes in pancreatic β-
cells of streptozotocin-treated diabetic rats. Method Find Exp. Clin. 
Pharmacol. 29(7): 447-455. 
Akah PA, Okafor CL (1992). Blood Sugar lowering effect of Vernonia 
amygdalina (Del) in an experimental rabbit model. Phytother. Res. 6: 
171-173. 
Avesani CM, Cuppari L, Silva AC, Sigulem DM, Cendoroglo M, Sesso 
R, Draibe SA (2001). Resting energy expenditure in predialysis 
diabetic patients. Nephrol. Dial. Transplant. 16: 556-560. 
Baerts M, Lehmann J (2006). Cissampelos owariensis. Medicinal Plants 
Database, Royal Museum for Central Africa, Tervuren, Belgium, 
http://www.metapro.belprelude.com. Accessed November, 2011. 
Burkhill JM (1994). The useful plants of West tropical Africa. 2
nd
 edition, 
volume 2, Families E-1. Royal Botanic Gardens, Kew Richmond, 
United kingdom. p. 626. 
Collier E, Watkinson A, Cleland CF, Roth J (1987). Partial purification 
and characterization of an insulin-like material from spinach and 
lemna gibba G3. J. Biol. Chem. 262: 6238-6241. 
Edem DO (2009). Hypoglycaemic effects of Ethanolic extracts of 
Alligator Pear seed (Persea Americana Mill) in Rat. Eur. J. Sci. Res. 
33(4): 669-678. 
Eddouks M, Jouad H, Maghrani M, Lemhadri A, Burcelin R (2003). 
Inhibition of endogenous glucose production accounts for 
hypoglycemic effect of Spergularia purpurea in streptozotocin mice. 
Phytomedicine: Int. J. Phytother. Phytopharmacol. 10(6-7): 594-599. 
Ekeanyanwu C, Njoku O (2010). Tigernut (Cyperus esculentus L); The 
Nutritive composition and some Biochemical Effect. Lambert 
Publishing GmbH, Germany, pp. 37-38.  
Gray AM, Flatt PR (1999). Insulin – releasing and insulin – like activity 
of the traditional antidiabetic plant Coriander sativum (coriander). Br. 





Harbone JB (1984). Phytochmical methods. A guide to modern 
techniques of plant analysis. 2
nd
 edition. Cahpman and Hall, London, 
pp. 4-26, 140-149. 
Iwu MM (1983). Hypoglycaemic Properties of Bridelia furruginear 
leaves. Fitoterapia, 54: 243-248 
Iwu MM (1980). Antidiabetic properties of Bridelia furruginear leaves. 
Planta Medica, 39: p. 247. 
Kesavulu MM, Giri R, Kameswara RB, Apparao C (2000). Lipid 
peroxidation and antioxidant enzyme levels in type 2 diabetes with 
micro vascular completion. Diabetic Metab. 26: 387-392.  
Khan A, Bryden NA, Polasky MN, Anderson RA (1990). Insulin-
potentiating factor and chromium content of selected spices. Biol. 
Trace Elem. Res. 24: 183-188.  
Lorke D (1983). A new approach for practical acute toxicity testing. 
Arch. Toxicol. pp. 275-287.  
Mahesh T, Menon PV (2004). Quercetin alleviates oxidative stress in 
streptozotocin induced diabetic rats. Phytother. Res. 18: 123-127. 
Marles RJ, Farnsworth NR (1995). Antidiabetic plants and their active 
constituents. Phytomed. 2: 137-189. 
 Musabayane CT, Bwititi PT, Ojewole, JAO (2006). Effect of oral 
administration of some herbal extracts on food consumption and 
blood glucose level in normal and streptozotocin treated diabetic rats. 
Method Find Exp. Clin. Pharmacol. 28(4): 223-228. 
Nawata K, Sohmiya M, Kawaguchi M, Nishiki M, Kato Y (2004). 
Increasing resting metabolic rate in patients diabetic nephropathy. 
Metab. 53: 1395-1398. 
Ogbonnia SO, Odimegwu JI, Enwuru VN (2008). Evaluation of 
hypoglycemic and hypolipidemic effects of ethanolic extracts of 
Treculia africana Decne and Bryophyllum pinnatum Lam. and their 
mixture on streptozotocin (STZ) - induced diabetic rats. Afr. J. 
Biotechnol. 7(15): 2535-2539. 
Ojewole JAO Adewole SO (2007). Hypoglycemic and hypotensive 
effects of Globimetula cupulata leaf extract in rats. CVJS, 18(1): 9-15. 
Ojewole JAO (2002). Hypoglycaemic effect of Clausena anisata (Willd) 
Hook methanolic root extract in rats. J. Ethnopharmacol. 81: 231-237. 
Owu DU, Antai AB, Udofia KH, Obembe AO, Obasi, KO, Eteng, MU 
(2006). Vitamin C improves basal metabolic rate and lipid profile in 
alloxan-induced diabetes mellitus in rats. J. Biosci. 31(5): 575-579. 
Ross IA (2001). Medicinal Plants of the World – Chemical Constituents, 
Traditional and Modern Medicinal Uses. Humana Press Inc. New 
Jersey, USA. pp. 30-45. 
Scoppola A, Montecchi FR, Mezinger G, Lala A (2001). Urinary 
mevalonate excretion rate in type 2 diabetes: role of metabolic 
control. Atherosclerosis, 156: 357-361. 
Shanmugasundaram ER, Gopith KI, Radha SK, Rajendram VM (1990). 
Possible regeneration of the islets of Langerhans in streptozocin 
diabetic rats given Gymnema sylvestere leaf extracts. J. Ethnopharm. 
30: 265-269. 
Sharma VK, Kumar S, Patel HJ, Hugar S (2010). Hypoglycaemic 
activity of Ficus glomerata in Alloxan induced diabetic rats. Int. J. 
Pharm. Sci. Res. 1(2): 18-22.  
Sri Balasubashini M, Rukkumani R, Viswanathan P, Menon PV (2004). 
Ferulic acid alleviates lipid peroxidation in diabetic rats. Phytother. 
Res. 18: 310-314. 
Trivedi NA, Mazumder B, Bhatt JD, Hemavathi KG (2004). Effect of 
Shilajit on blood glucose and lipid profile in alloxan induced diabetic 
rats. Indian J. Pharmacol. 36: 373-376. 
Ugochukwu NH, Babady NE, Cobourne M, Gasset SR (2003). The 
effect of Gangronema latifolium extracts on serum lipid profile and 
oxidative stress in hepatocytes of diabetic rats. J. Biosci. 28(1): 1-5. 
Unwin N, Sobngwi E, Alberti KGMM (2001). Type 2 diabetes: the 
challenge of preventing a global epidemic. Diabetes Int. 11: 4-8. 
Yadav JP, Saini S, Kalia AN, Dangi AS (2008). Hypoglycemic activity of 
ethanolic extract of Salvadora oleoides in normal and alloxan – 
induced diabetes rats. Indian J. Pharmacol. 40(1): 23-27. 
 
